Correlation of echocardiography parameters with cardiac magnetic resonance imaging in transfusion-dependent thalassaemia major

被引:18
|
作者
Aessopos, Athanassios
Giakoumis, Anastasios
Fragodimitri, Christina
Karabatsos, Fotis
Hatziliami, Antonia
Yousef, Jacqueline
Gotsis, Efstathios
Berdoukas, Vasilis
Karagiorga, Markissia
机构
[1] Univ Athens, Laiko Gen Hosp, Dept Med 1, Athens 11527, Greece
[2] Aghia Sophia Childrens Hosp, Thalassemia Unit, Athens, Greece
[3] Euromed Enkephalos, Athens, Greece
关键词
thalassaemia major; cardiac magnetic resonance imaging; echocardiography-Doppler; transfusion iron overload; chelation therapy;
D O I
10.1111/j.1600-0609.2006.00770.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and objective: Heart iron load (cardiac Fe) can be indirectly quantified by cardiac magnetic resonance (CMR) T2*. CMR accessibility is limited, whereas echocardiography (Echo) is relatively inexpensive and readily available. The objective was to find Echo parameters that may be useful for predicting cardiac Fe. Design and methods: We compared a number of parameters derived from Echo to cardiac Fe in 142 thalassaemia major patients who had undergone a CMR study. Results: All patients with decreased left ventricular (LV) function had cardiac Fe. After removing those patients from the analysis, the total diameter index (Tdi) > 5.57 cms/m(2), left atrial diameter index > 2.41 cm/m(2), and the diastolic parameter E/A > 1.96 were highly specific (91.4%, 97.1% and 96.9% respectively) but had low sensitivity (31.8%, 20.45% and 21.8%) in predicting iron load. A right ventricular index > 1.47 cm/m(2), LV systolic index > 2.26 cm/m(2) or Tdi > 6.26 cm/m(2) discriminated between patients with no, or mild to moderate cardiac Fe from those with heavy load, with specificity of 91%, 98.5%, and 98.5%, respectively, but with low sensitivity. Interpretation and conclusions: Echo parameters for cardiac Fe prediction have restricted value, whereas CMR is essential to assess cardiac Fe. However, patients with decreased LV systolic function should be considered a priori as having cardiac Fe, and chelation therapy should be intensified. This also applies to patients who have the above-described Echo criterion values, even if CMR is not available. Once a patient is found by CMR to have cardiac Fe, then the above Echo criterion values may be useful for ongoing monitoring.
引用
收藏
页码:58 / 65
页数:8
相关论文
共 50 条
  • [41] Cardiac magnetic resonance in transfusion dependent thalassaemia: assessment of iron load and relationship to left ventricular ejection fraction
    Chouliaras, Giorgos L.
    Kattamis, Antonis
    Berdoukas, Vasilis
    Gotsis, Efstathios D.
    Mavrogeni, Sophie
    Ladis, Vassilis
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 151 (04) : 397 - 401
  • [42] Prevalence of growth and endocrine disorders in Malaysian children with transfusion-dependent thalassaemia
    Tan, Khian Aun
    Lum, Su Han
    Yahya, Abqariyah
    Krishnan, Shekhar
    Jalaludin, Muhammad Yazid
    Lee, Way Seah
    SINGAPORE MEDICAL JOURNAL, 2019, 60 (06) : 303 - 308
  • [43] Red cell alloimmunization and autoantibodies in Egyptian transfusion-dependent thalassaemia patients
    Ahmed, Azza Mohamed
    Hasan, Nehal Salah
    Ragab, Shadia Hassan
    Habib, Sonia Adolf
    Emara, Nahed Abdelmonem
    Aly, Azza Ahmed
    ARCHIVES OF MEDICAL SCIENCE, 2010, 6 (04) : 592 - 598
  • [44] Red blood cell alloimmunisation in transfusion-dependent thalassaemia: a systematic review
    Franchini, Massimo
    Forni, Gian Luca
    Marano, Giuseppe
    Cruciani, Mario
    Mengoli, Carlo
    Pinto, Valeria
    De Franceschil, Lucia
    Venturelli, Donatella
    Casale, Maddalena
    Amerini, Martina
    Capuzzo, Martina
    Grazzinil, Giuliano
    Masiello, Francesca
    Pati, Ilaria
    Veropalumbo, Eva
    Vaglio, Stefania
    Pupella, Simonetta
    Liumbruno, Giancarlo M.
    BLOOD TRANSFUSION, 2019, 17 (01) : 4 - 15
  • [45] High frequency of autoimmunization among transfusion-dependent Tunisian thalassaemia patients
    Guirat-Dhouib, N.
    Mezri, M.
    Hmida, H.
    Mellouli, F.
    Kaabi, H.
    Ouderni, M.
    Zouari, B.
    Hmida, S.
    Bejaoui, M.
    TRANSFUSION AND APHERESIS SCIENCE, 2011, 45 (02) : 199 - 202
  • [46] Luspatercept: A Review in Transfusion-Dependent Anaemia due to Myelodysplastic Syndromes or β-Thalassaemia
    Connie Kang
    Yahiya Y. Syed
    Drugs, 2021, 81 : 945 - 952
  • [47] 2021 Thalassaemia International Federation Guidelines for the Management of Transfusion-dependent Thalassemia
    Farmakis, Dimitrios
    Porter, John
    Taher, Ali
    Cappellini, Maria Domenica
    Angastiniotis, Michael
    Eleftheriou, Androulla
    HEMASPHERE, 2022, 6 (08):
  • [48] What we now BELIEVE is achievable with luspatercept in transfusion-dependent β-thalassaemia
    Musallam, Khaled
    LANCET HAEMATOLOGY, 2025, 12 (03): : e164 - e165
  • [49] Luspatercept: A Review in Transfusion-Dependent Anaemia due to Myelodysplastic Syndromes or β-Thalassaemia
    Kang, Connie
    Syed, Yahiya Y.
    DRUGS, 2021, 81 (08) : 945 - 952
  • [50] The correlation between cardiac magnetic resonance imaging and echocardiography in patients with severe ischaemic cardiomyopathy
    Betemariam, T.
    Morgan, H.
    Mancio, J.
    Alskaf, E.
    Ryan, M.
    Draper, J.
    Papachristidis, A.
    Senior, R.
    Kapetanakis, S.
    Chiribiri, A.
    Perera, D.
    EUROPEAN HEART JOURNAL, 2024, 45